About Trans Ova Genetics
Trans Ova Genetics is a company based in Sioux Center (United States) founded in 1980 was acquired by Precigen in July 2014. Trans Ova Genetics has raised $9 million across 1 funding round from investors including Precigen and Iowa Values Fund. The company has 1 employees as of April 07, 2024. Trans Ova Genetics has completed 1 acquisition, including ViaGen. Trans Ova Genetics offers products and services including In Vitro Fertilization and Embryo Transfer.
- Headquarter Sioux Center, United States
- Employees 1 as on 07 Apr, 2024
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trans Ova Laboratories India Private Limited
- Date of Incorporation 14 Aug, 2020
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$8.54 K (USD)0as on Mar 31, 2023
-
Net Profit
$5.99 K (USD)1074592.88as on Mar 31, 2023
-
EBITDA
$8.54 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$9 M (USD)
in 1 rounds
-
Latest Funding Round
$9 M (USD), Private Equity Round
Aug 28, 2003
-
Investors
Precigen
& 1 more
-
Employee Count
1
as on Apr 07, 2024
- Investments & Acquisitions
-
Acquired by
Precigen
(Jul 01, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trans Ova Genetics
Trans Ova Genetics offers a comprehensive portfolio of products and services, including In Vitro Fertilization and Embryo Transfer.
In vitro fertilization is offered for advancing genetics in animals such as dairy and beef cattle
Embryo transfer is utilized to multiply herd genetics and achieve breeding objectives in livestock
People of Trans Ova Genetics
Unlock access to complete
Unlock access to complete
Funding Insights of Trans Ova Genetics
Trans Ova Genetics has successfully raised a total of $9M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $9 million completed in August 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Trans Ova Genetics
Trans Ova Genetics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Precigen and Iowa Values Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
|
Locked | Locked | Locked |
Investor details for Trans Ova Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trans Ova Genetics
Trans Ova Genetics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ViaGen.
Investment portfolio details for Trans Ova Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloning services for livestock and pets are offered by Viagen.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Trans Ova Genetics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Trans Ova Genetics
Detailed financials for Trans Ova Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trans Ova Genetics Comparisons
Peer comparison for Trans Ova Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trans Ova Genetics
Detailed competitors of Trans Ova Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trans Ova Genetics
Complete news archive for Trans Ova Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trans Ova Genetics
Trans Ova Genetics was founded in 1980 and raised its 1st funding round 23 years after it was founded.
Trans Ova Genetics is headquartered in Sioux Center, United States. It is registered at Sioux Center, Iowa, United States.
Trans Ova Genetics is a funded company, having raised a total of $9M across 1 funding round to date.
As of Apr 07, 2024, the latest employee count at Trans Ova Genetics is 1.
Annual revenue of Trans Ova Genetics is $8.54K as on Mar 31, 2023.
Trans Ova Genetics was established in 1980 in Sioux Center, United States, within the livestock agribusiness sector. Services focused on genetic preservation and reproduction for ruminants are delivered, including embryo transfer, in vitro fertilization, sexed semen, cryo-preservation for cloning, and related consultations. Operations are managed through regional centers in Iowa, Texas, Maryland, and Missouri, supplemented by satellite facilities.
Trans Ova Genetics offers In Vitro Fertilization and Embryo Transfer.
Trans Ova Genetics has made 1 acquisition, including ViaGen.
Trans Ova Genetics has 2 investors. Key investors include Precigen, and Iowa Values Fund.